Isomorphic Labs and MSD Enter Strategic Research Collaboration
<p>LONDON, Nov. 19, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and development company, and MSD, trade name of Merck & Co., Inc., Rahway, NJ, USA, today announced a research collaboration that brings together Isomorphic Labs' AI approach to drug discovery with MSD's rich...</p>
Read original article ↗